Pharming Group N.V.PHARNASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank31
Year-over-Year Change
Year-over-year book value per share growth
Percentile
P31
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -5.90% |
| Q2 2025 | 11.27% |
| Q1 2025 | -0.97% |
| Q4 2024 | -7.00% |
| Q3 2024 | 43.65% |
| Q2 2024 | 6.91% |
| Q1 2024 | -12.77% |
| Q4 2023 | 7.75% |
| Q3 2023 | -13.11% |
| Q2 2023 | 24.36% |
| Q1 2023 | -10.20% |
| Q4 2022 | 1.36% |
| Q3 2022 | 11.72% |
| Q2 2022 | 8.67% |
| Q1 2022 | -15.68% |
| Q4 2021 | 0.00% |
| Q2 2021 | 4.63% |
| Q1 2021 | 5.80% |
| Q4 2020 | 10.21% |
| Q3 2020 | 8.18% |
| Q2 2020 | 9.42% |
| Q1 2020 | -0.68% |
| Q4 2019 | 18.59% |
| Q3 2019 | 6.18% |
| Q2 2019 | 13.59% |
| Q1 2019 | 9.80% |
| Q4 2018 | 26.19% |
| Q3 2018 | 7.76% |
| Q2 2018 | 32.76% |
| Q1 2018 | 57.01% |
| Q4 2017 | 209.26% |
| Q3 2017 | -18.57% |
| Q2 2017 | -74.98% |
| Q1 2017 | 7.06% |
| Q4 2016 | 71.86% |
| Q3 2016 | -25.93% |
| Q2 2016 | -15.91% |
| Q1 2016 | -7.85% |
| Q4 2015 | -9.44% |
| Q3 2015 | -11.28% |